Biomedical Computer Technologies NyRt. (FRA:BCT) EV-to-EBITDA : -11.85 (As of Jun. 07, 2024)

Biomedical Computer Technologies NyRt. EV-to-EBITDA Chart

Biomedical Computer Technologies NyRt. Annual Data
	Trend	Dec11	Dec12	Dec13	Dec14	Dec15	Dec16	Dec17	Dec18	Dec19	Dec20
EV-to-EBITDA		Get a 7-Day Free Trial					-5.66	-73.12	23.13	14.99	29.23

Biomedical Computer Technologies NyRt. Semi-Annual Data
	Dec11	Jun12	Dec12	Jun13	Dec13	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21
EV-to-EBITDA	Get a 7-Day Free Trial															-	14.99	-	29.23	-

Competitive Comparison of Biomedical Computer Technologies NyRt.'s EV-to-EBITDA

For the Specialty Industrial Machinery subindustry, Biomedical Computer Technologies NyRt.'s EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Biomedical Computer Technologies NyRt.'s EV-to-EBITDA Distribution in the Industrial Products Industry

For the Industrial Products industry and Industrials sector, Biomedical Computer Technologies NyRt.'s EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Biomedical Computer Technologies NyRt.'s EV-to-EBITDA falls into.

Biomedical Computer Technologies NyRt. EV-to-EBITDA Calculation

Biomedical Computer Technologies NyRt.'s EV-to-EBITDA for today is calculated as:

Biomedical Computer Technologies NyRt.'s current Enterprise Value is €5.61 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Biomedical Computer Technologies NyRt.'s EBITDA for the trailing twelve months (TTM) ended in Jun. 2021 was €-0.47 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Biomedical Computer Technologies NyRt.  (FRA:BCT) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Biomedical Computer Technologies NyRt.'s PE Ratio for today is calculated as:

Biomedical Computer Technologies NyRt.'s share price for today is €0.14.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Biomedical Computer Technologies NyRt.'s Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2021 was €0.000.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?

Biomedical Computer Technologies NyRt. EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Biomedical Computer Technologies NyRt.'s EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.

Biomedical Computer Technologies NyRt. (FRA:BCT) Business Description